Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Saibeni

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Expert Opinion on Biological Therapy|May 10, 2025
Second-line strategies after anti-TNF failure in chronically active, moderate-to-severe ulcerative colitis: a retrospective, multicentre cohort studyBernadett Farkas, Jimmy K Limdi, Péter Bacsur, et al.
European Journal of Gastroenterology & Hepatology|October 1, 2019
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' studyAnna Viola, Rita Monterubbianesi, Giuseppe Scalisi, et al.
Journal of Crohn'S & Colitis|April 1, 2025
Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort studyDaniele Noviello, María Chaparro, Chiara Viganò, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 9, 2016
Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD "AGED study"Walter Fries, Anna Viola, Natalia Manetti, et al.
BMC Gastroenterology|July 5, 2023
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic wavesCristina Bezzio, Marta Vernero, Stefania Costa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 1, 2025
Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian StudyCristina Della Corte, Daphne D'Amato, Adele Rocchetti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 6, 2025
Adaptation of the European Crohn's Colitis Organisation quality of care standards to Italy: The Italian Group for the study of inflammatory bowel disease consensusGionata Fiorino, Flavio Andrea Caprioli, Sara Onali, et al.
Inflammatory Bowel Diseases|April 2, 2022
Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational StudyGaetano Bergamaschi, Fabiana Castiglione, Renata D'Incà, et al.
United European Gastroenterology Journal|October 19, 2020
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of careSimone Saibeni, Ludovica Scucchi, Gabriele Dragoni, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 30, 2026
Ustekinumab and JAK inhibitors outperform vedolizumab as second-line therapy in anti-TNF-experienced patients with ulcerative colitisGiuseppe Privitera, Cristina Bezzio, Gisella Figlioli, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Expert Opinion on Biological Therapy|May 10, 2025
Second-line strategies after anti-TNF failure in chronically active, moderate-to-severe ulcerative colitis: a retrospective, multicentre cohort studyBernadett Farkas, Jimmy K Limdi, Péter Bacsur, et al.
European Journal of Gastroenterology & Hepatology|October 1, 2019
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' studyAnna Viola, Rita Monterubbianesi, Giuseppe Scalisi, et al.
Journal of Crohn'S & Colitis|April 1, 2025
Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort studyDaniele Noviello, María Chaparro, Chiara Viganò, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 9, 2016
Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD "AGED study"Walter Fries, Anna Viola, Natalia Manetti, et al.
BMC Gastroenterology|July 5, 2023
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic wavesCristina Bezzio, Marta Vernero, Stefania Costa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 1, 2025
Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian StudyCristina Della Corte, Daphne D'Amato, Adele Rocchetti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 6, 2025
Adaptation of the European Crohn's Colitis Organisation quality of care standards to Italy: The Italian Group for the study of inflammatory bowel disease consensusGionata Fiorino, Flavio Andrea Caprioli, Sara Onali, et al.
Inflammatory Bowel Diseases|April 2, 2022
Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational StudyGaetano Bergamaschi, Fabiana Castiglione, Renata D'Incà, et al.
United European Gastroenterology Journal|October 19, 2020
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of careSimone Saibeni, Ludovica Scucchi, Gabriele Dragoni, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 30, 2026
Ustekinumab and JAK inhibitors outperform vedolizumab as second-line therapy in anti-TNF-experienced patients with ulcerative colitisGiuseppe Privitera, Cristina Bezzio, Gisella Figlioli, et al.
Pageof 11